drugset / Trial / NCT01729468

Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers

NCT01729468 ↗

Phase 4 Completed 1106 enrolled University Hospital, Tours
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The objective of this study is to test the efficacy of low-dose aspirin (160 mg/day), given bedtime and started early during pregnancy (≤ 15 +6 weeks of gestation) in nulliparous pregnant women selected as "high-risk" by the presence of a bilateral uterine artery notch and/or bilateral uterine artery PI ≥ 1.7 during the first trimester ultrasound scan (11-13+6 weeks), to prevent the occurrence of pre-eclampsia or small for gestational age at birth.

Timeline

Start
2012-06-27
Primary completion
2016-10-25
Completion
2016-10-25

Outcome

Missed primary endpoint

paper proportion difference 1.6 [-2.6; 5.9] p = 0.45 PMID 36260615 ↗

paper Low-dose aspirin was not associated with a lower rate of either preeclampsia or birthweight ≤ 5th percentile PMID 36260615 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 160 mg —